ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
ABRIDGED HANDBOOK
Note: this table includes only the recommendations from reports and the resolve statements from resolutions. The table includes all items of business excepting informational reports. Only the primary sponsor, usually the submitter, is listed for resolutions. († Only the first organization is listed for those resolutions sponsored by multiple entities)
2
Cmte*ItemSponsor† TitleRecommendations or Resolves
54
BBOT 09n/aCouncil on Legislation Sunset Review of 2014 House PoliciesThe Board of Trustees recommends that the House of Delegates policies that are listed in the appendix to this report be acted upon in the manner indicated and the remainder of this report be filed.
55
BBOT 11n/aSafe and Effective Overdose Reversal Medications in Educational SettingsThe Board of Trustees recommends that the following be adopted, and that the remainder of the report be filed:
1. Existing American Medical Association (AMA) policy entitled, “Increasing Availability of Naloxone and Other Safe and Effective Overdose Reversal Medications” (Policy H-95.932), be reaffirmed, and (Reaffirm HOD Policy)
2. The third resolve of Policy H-95.908, “Increase Access to Safe and Effective Overdose Reversal Medications in Educational Settings” be rescinded and that the policy be updated as noted. (Modify Current HOD Policy)
1. Our AMA will encourage states, communities, and educational settings to adopt legislative and regulatory policies that allow schools to make safe and effective overdose reversal medications readily accessible to staff and teachers to prevent opioid overdose deaths in educational settings.
2. Our AMA will encourage states, communities, and educational settings to remove barriers to students carrying safe and effective overdose reversal medications.
3. Our AMA will study and report back on issues regarding student access to safe and effective overdose reversal medications.
56
BBOT 13n/aProhibiting Covenants Not-to-CompeteThe Board of Trustees recommends that the following policy be adopted, and the remainder of the report be filed:
1. That the American Medical Association (AMA) continue to assist interested state medical associations in developing fair and reasonable strategies regarding restrictive covenants between physician employers and physician employees including regularly updating the AMA’s state restrictive covenant legislative template. (New HOD Policy)
57
BBOT 14n/aPhysician Assistant and Nurse Practitioner Movement Between SpecialtiesThe Board of Trustees recommends that the following policy be adopted, and the remainder of the report be filed:
1. That the American Medical Association (AMA) support workforce research, including surveys by state medical and nursing boards, that specifically focus on gathering information on nurse practitioners and physician assistants practicing in specialty care, their certification(s), alignment of their certification to their specialty, and whether they have switched specialties during their career. (New HOD Policy)
2. That the AMA support research that evaluates the impact of specialty switching by nurse practitioners and physician assistants on the cost and quality of patient care. (New HOD Policy)
3. That the AMA encourage hospitals and other health care entities employing nurse practitioners to ensure that the nurse practitioner’s certification aligns with the specialty in which they will practice. (New HOD Policy)
4. That the AMA continue educating policymakers and lawmakers on the education, training, and certification of nurse practitioners and physician assistants, including the concept of specialty switching. (New HOD Policy)
58
BBOT 15 (1of4)n/aAugmented Intelligence Development, Deployment, and Use in Health CareThe Board of Trustees recommends that the following be adopted in lieu of Resolution 206-I-23 and that the remainder of the report be filed:

AUGMENTED INTELLIGENCE DEVELOPMENT, DEPLOYMENT, AND USE IN HEALTH CARE

General Governance
• Health care AI must be designed, developed, and deployed in a manner which is ethical, equitable, responsible, and transparent.
• Use of AI in health care delivery requires clear national governance policies to regulate its adoption and utilization, ensuring patient safety, and mitigating inequities. Development of national governance policies should include interdepartmental and interagency collaboration.
• Compliance with national governance policies is necessary to develop AI in an ethical and responsible manner to ensure patient safety, quality, and continued access to care. Voluntary agreements or voluntary compliance is not sufficient.
• Health care AI requires a risk-based approach where the level of scrutiny, validation, and oversight should be proportionate to the potential overall of disparate harm and consequences the AI system might introduce. [See also Augmented Intelligence in Health Care H-480.939 at (1)]
• Clinical decisions influenced by AI must be made with specified human intervention points during the decision-making process. As the potential for patient harm increases, the point in time when a physician should utilize their clinical judgment to interpret or act on an AI recommendation should occur earlier in the care plan.
• Health care practices and institutions should not utilize AI systems or technologies that introduce overall or disparate risk that is beyond their capabilities to mitigate. Implementation and utilization of AI should avoid exacerbating clinician burden and should be designed and deployed in harmony with the clinical workflow.
• Medical specialty societies, clinical experts, and informaticists are best positioned and should identify the most appropriate uses of AI-enabled technologies relevant to their clinical expertise and set the standards for AI use in their specific domain. [See Augmented Intelligence in Health Care H-480.940 at (2)]
59
BBOT 15 (2of4)n/aAugmented Intelligence Development, Deployment, and Use in Health CareWhen to Disclose: Transparency in Use of Augmented Intelligence-Enabled Systems and Technologies

• When AI is used in a manner which directly impacts patient care, access to care, or medical decision making, that use of AI should be disclosed and documented to both physicians and/or patients in a culturally and linguistically appropriate manner. The opportunity for a patient or their caregiver to request additional review from a licensed clinician should be made available upon request.
• When AI is used in a manner which directly impacts patient care, access to care, medical decision making, or the medical record, that use of AI should be documented in the medical record.
• AI tools or systems cannot augment, create, or otherwise generate records, communications, or other content on behalf of a physician without that physician’s consent and final review.
• When health care content is generated by generative AI, including by large language models, it should be clearly disclosed within the content that was generated by an AI-enabled technology.
• When AI or other algorithmic-based systems or programs are utilized in ways that impact patient access to care, such as by payors to make claims determinations or set coverage limitations, use of those systems or programs must be disclosed to impacted parties.
• The use of AI-enabled technologies by hospitals, health systems, physician practices, or other entities, where patients engage directly with AI should be clearly disclosed to patients at the beginning of the encounter or interaction with the AI-enabled technology.
60
BBOT 15 (3of4)n/aAugmented Intelligence Development, Deployment, and Use in Health Care• When AI-enabled systems and technologies are utilized in health care, the following information should be disclosed by the AI developer to allow the purchaser and/or user (physician) to appropriately evaluate the system or technology prior to purchase or utilization:
-Regulatory approval status
-Applicable consensus standards and clinical guidelines utilized in design, development, deployment, and continued use of the technology
-Clear description of problem formulation and intended use accompanied by clear and detailed instructions for use
-Intended population and intended practice setting
-Clear description of any limitations or risks for use, including possible disparate impact
-Description of how impacted populations were engaged during the AI lifecycle
-Detailed information regarding data used to train the model:
•Data provenance
•Data size and completeness
•Data timeframes
•Data diversity
•Data labeling accuracy
-Validation Data/Information and evidence of:
•Clinical expert validation in intended population and practice setting and intended clinical outcomes
•Constraint to evidence-based outcomes and mitigation of “hallucination” or other output error
•Algorithmic validation
•External validation processes for ongoing evaluation of the model performance, e.g., accounting for AI model drift and degradation
•Comprehensiveness of data and steps taken to mitigate biased outcomes
•Other relevant performance characteristics, including but not limited to performance characteristics at peer institutions/similar practice settings
•Post-market surveillance activities aimed at ensuring continued safety, performance, and equity
-Data Use Policy
•Privacy
•Security
•Special considerations for protected populations or groups put at increased risk
-Information regarding maintenance of the algorithm, including any use of active patient data for ongoing training
-Disclosures regarding the composition of design and development team, including diversity and conflicts of interest, and points of physician involvement and review
61
BBOT 15 (4of4)n/aAugmented Intelligence Development, Deployment, and Use in Health Care• Purchasers and/or users (physicians) should carefully consider whether or not to engage with AI-enabled health care technologies if this information is not disclosed by the developer. As the risk of AI being incorrect increases risks to patients (such as with clinical applications of AI that impact medical decision making), disclosure of this information becomes increasingly important. [See also Augmented Intelligence in Health Care H-480.939]
62
BBOT 16n/aSupport for Mental Health CourtsThe Board of Trustees recommends that existing policy – Policy H-100.955, entitled, “Support for Drug Courts” – be amended by addition and deletion in lieu of Resolution 202 as follows:
Support for Diversion Programs, Including Drug Courts, Mental Health Courts, Veterans Courts, Sobriety Courts, and Similar Programs

Our AMA:
(1) supports the establishment and use of diversion and treatment programs drug courts, including drug courts, mental health courts, veterans courts, sobriety courts, and other types of similar programs, as an effective method of intervention within a comprehensive system of community-based supports and services for individuals with a mental illness or substance use disorder involved in the justice system addictive disease who are convicted of nonviolent crimes;
(2) encourages legislators and court systems to establish diversion and treatment programs drug courts at the state and local level in the United States; and
(3) encourages diversion and treatment programs drug courts to rely upon evidence-based models of care, including medications for opioid use disorder, for those who the judge or court determine would benefit from intervention, including treatment, rather than incarceration; and
(4) supports individuals enrolled in diversion or treatment programs not be removed from a program solely because of evidence showing that an individual used illegal drugs while enrolled. (Modify HOD Policy)
63
BBOT 17n/aDrug Policy ReformThe Board of Trustees recommends that the following recommendations be adopted in lieu of Resolution 203 and the remainder of the report be filed:

1.That the American Medical Association (AMA) will continue to monitor the legal and public health effects of state and federal policies to reclassify criminal offenses for drug possession for personal use; (New HOD Policy)
2. That the AMA will support federal and state efforts to expunge, at no cost to the individual, criminal records for drug possession for personal use upon completion of a sentence or penalty; (New HOD Policy) and
3. That the AMA support programs that provide comprehensive substance use disorder treatment and social support to people who use or possess illicit drugs for personal use as an alternative to incarceration-based penalties for persons under parole, probation, pre-trial, or other civic, criminal, or judicial supervision. (New HOD Policy)
64
BBOT 18n/aSupporting Harm ReductionThe Board of Trustees recommends that the following new policy be adopted in lieu of Resolution 204, and that the remainder of the report be filed.
1. That the American Medical Association (AMA) support efforts to decriminalize the possession of non-prescribed buprenorphine for personal use by individuals who lack access to a physician for the treatment of opioid use disorder; (New HOD Policy)
2. That the AMA oppose the concept, promotion, or practice of “safe smoking” with respect to inhalation of tobacco, cannabis or any illicit substance; (New HOD Policy)
3. That the AMA encourage additional study whether “safer smoking supplies” may be a potential harm reduction measure to reduce harms from the nation’s overdose and death epidemic; and (New HOD Policy)
4. That the AMA reaffirm Policy D-95.987, “Prevention of Drug-Related Overdose.” (Reaffirm AMA Policy)
65
BBOT 19n/aAttorneys’ Retention of Confidential Medical Records and Controlled Medical Expert’s Tax Returns After Case Adjudication The Board of Trustees recommends that the following be adopted in lieu of Resolution 240-A-23 and the remainder of this report be filed:
1. That our American Medical Association advocate that attorneys’ discovery requests for the personal tax returns of a medical expert for the opposing party should usually be limited to 1099-MISC forms (miscellaneous income) (New HOD Policy); and
2. RESOLVED, That our AMA support through legislative or other relevant means the proper return or destruction of client medical records and medical expert’s personal tax returns by attorneys within sixty days of the conclusion of the litigation (New HOD Policy).
66
BRes. 201American Academy of OpthalmologyResearch Correcting Political Misinformation and Disinformation on Scope of PracticeRESOLVED, that our American Medical Association perform a comprehensive literature review on current research on correcting political misinformation and disinformation and conduct field research on ways to correct political misinformation and disinformation amongst policymakers as it pertains to scope of practice (Directive to Take Action);

RESOLVED, that our AMA Board of Trustees report its findings and recommendations by the I-24 meeting to the HOD on correcting political misinformation and disinformation and that our AMA incorporate these findings to the extent possible into our AMA’s advocacy efforts on scope of practice. (Directive to Take Action)
67
BRes. 202American Association of Clinical UrologistsUse of Artificial Intelligence and Advanced Technology by Third Party Payors to Deny Health Insurance ClaimsRESOLVED, that our American Medical Association adopt as policy that Commercial third-party payors, Medicare, Medicaid, Workers Compensation, Medicare Advantage and other health plans ensure they are making medical necessity determinations based on the circumstances of the specific patient rather than by using an algorithm, software, or Artificial Intelligence (AI) that does not account for an individual’s circumstances (New HOD Policy)

RESOLVED, that our AMA adopt as policy that coverage denials based on a medical necessity determination must be reviewed by a physician in the same specialty or by another appropriate health care professional for non-physician health care providers. (New HOD Policy)
68
BRes. 203FloridaMedicaid Patient AccountabilityRESOLVED, that our American Medical Association advocate that physicians’ Healthcare Effectiveness Data and Information Set and other quality scores and ratings not be affected by non-compliant patients or patients whose parents exercise state exemptions from recommended treatment. (Directive to Take Action)
69
BRes. 204FloridaStaffing Ratios in the Emergency DepartmentRESOLVED, that our American Medical Association seek federal legislation or regulation prohibiting staffing ratios that do not allow for proper supervision of NPPs in the Emergency Department (Directive to Take Action)

RESOLVED, that our AMA seek federal legislation or regulation that would require all Emergency Departments to be staffed 24-7 by a qualified physician. (Directive to Take Action)
70
BRes. 205Medical Student SectionMedical-Legal Partnerships & Legal Aid ServicesRESOLVED, that our American Medical Association support the establishment and funding of medical-legal partnerships and civil legal aid services to meet patients’ legal needs. (New HOD Policy)
71
BRes. 206Medical Student SectionIndian Health Service Youth Regional Treatment CentersRESOLVED, that our American Medical Association support the expansion of Indian Health Service Youth Regional Treatment Centers, recognizing them as a model for culturally-rooted, evidence-based behavioral health treatment, and prompt referral of eligible AI/AN youth to Youth Regional Treatment Centers (YRTCs) for community-directed care. (New HOD Policy)
72
BRes. 207Medical Student SectionBiosimilar Use Rates and Prevention of Pharmacy Benefit Manager AbuseRESOLVED, that our American Medical Association support economic incentives to increase physician use of less expensive biosimilars instead of their reference biologics (New HOD Policy);

RESOLVED, that our AMA encourage the Federal Trade Commission (FTC) and Department of Justice (DOJ) Antitrust Division to closely scrutinize long-term exclusive contracts signed between biologics originators and PBMs to ensure they do not impede biosimilar development and uptake. (New HOD Policy)
73
BRes. 208Medical Student SectionImproving Supplemental Nutrition Programs RESOLVED, that our American Medical Association support regulatory and legal reforms to extend multieligibility for USDA Food Assistance to enrolled members of federally-recognized American Indian and Alaska Native Tribes and Villages to all federal feeding programs, such as, but not limited to, Supplemental Nutrition Assistance Program (SNAP) and Food Distribution Program on Indian Reservations (FDPIR). (New HOD Policy)
74
BRes. 209Medical Student SectionNative American Voting RightsRESOLVED, that our American Medical Association support Indian Health Service, Tribal, and Urban Indian Health Programs becoming designated voter registration sites to promote nonpartisan civic engagement among the American Indian and Alaska Native population. (New HOD Policy)
75
BRes. 210OregonSupport for Physicians Pursuing Collective Bargaining and UnionizationRESOLVED, that our American Medical Association convenes an updated study of opportunities for the AMA or physician associations to support physicians initiating a collective bargaining process, including but not limited to unionization. (Directive to Take Action)
76
BRes. 211Organized Medical Staff SectionDeceptive Hospital Badging 2.0RESOLVED, that our American Medical Association promote and prioritize public awareness of the difference and importance of having the proper level of training and clear identification and labeling of caregivers as that relates to quality and safety of healthcare (Directive to Take Action)

RESOLVED, that our AMA work with state and county medical societies to highlight to physicians the growing practice of creating false equivalencies between physicians and non-physicians in the healthcare team and encourage action in local institutions to assure the quality and safety of patient care. (Directive to Take Action)
77
BRes. 212Organized Medical Staff SectionAdvocacy Education Towards a Sustainable Medical Care SystemRESOLVED, that our American Medical Association explore innovative opportunities for engaging the public in advocacy on behalf of an improved healthcare environment. (Directive to Take Action)
78
BRes. 213Private Practice Physicians SectionAccess to Covered Benefits with an Out of Network Ordering PhysicianRESOLVED, that our American Medical Association develop model legislation to protect patients in direct primary care plans and non-network plans thus furthering the ability of direct primary care physicians and other out-of-network physicians to provide covered services, including imaging, laboratory testing, referrals, medications, and other medically-necessary services for patients under their commercial insurance, even if it is an HMO or point of service plan (Directive to Take Action)

RESOLVED, that our AMA develop resources, tool kits, education, and internal experts to support direct primary care and other out-of-network models. (Directive to Take Action)
79
BRes. 214Medical Student SectionSupport for Paid Sick LeaveRESOLVED, that our American Medical Association amend Policy H-440.823, “Paid Sick Leave,” as follows:
Paid Sick Leave H-440.823
Our AMA: (1) recognizes the public health benefits of paid sick leave and other discretionary paid time off; (2) supports employer policies that allow employees to accrue paid time off and to use such time to care for themselves or a family member; and (3) supports employer policies that provide employees with paidsick days to use to care for themselves or a family member where providing paid leave is overly burdensome; and (4) advocates for federal and state policies that guarantee employee access to protected paid sick leave. (Modify Current HOD Policy)
80
BRes. 215Medical Student SectionAmerican Indian and Alaska Native Language Revitalization and Elder CareRESOLVED, that our American Medical Association recognize that access to language concordant services for AI/AN patients will require targeted investment as Indigenous languages in North America are threatened due to a complex history of removal and assimilation by state and federal actors (New HOD Policy);

RESOLVED, that our AMA support federal-tribal funding opportunities for American Indian and Alaska Native language revitalization efforts, especially those that increase health information resources and access to language-concordant health care services for American Indian and Alaska Native elders living on or near tribal lands (New HOD Policy);

RESOLVED, that our AMA collaborate with stakeholders, including but not limited to the National Indian Council on Aging and Association of American Indian Physicians, to identify best practices for AI/AN elder care to ensure this group is provided culturally-competent healthcare outside of the umbrella of the Indian Health Service. (Directive to Take Action)
81
BRes. 216American College of Legal MedicineThe AMA Supports H.R. 7225, the Bipartisan “Administrative Law Judges Competitive Service Restoration Act”RESOLVED, that our American Medical Association support H.R. 7225, the bipartisan “Administrative Law Judges Competitive Service Restoration Act” that supports the merit-based process for the selection of all Medicare/Medicaid Administrative Law Judges. (New HOD Policy)
82
BRes. 217American Society for Reproductive MedicineProtecting Access to IVF TreatmentRESOLVED, that our American Medical Association oppose any legislation or ballot measures that could criminalize in-vitro fertilization (New HOD Policy);

RESOLVED, that our AMA work with other interested organizations to oppose any legislation or ballot measures or court rulings that equate gametes (oocytes and sperm) or embryos with children (New HOD Policy)

RESOLVED, that our AMA report back at A-25, on the status of, and AMA’s activities surrounding, ballot measures, court rulings, and legislation that equate embryos with children. (Directive to Take Action)
83
BRes. 218MichiganDesignation of Descendants of Enslaved Africans in AmericaRESOLVED, that our American Medical Association work with appropriate organizations including, but not limited to, the Association of American Medical Colleges to adopt and define the term Descendants of Enslaved Africans in America and separate if from the generic terms African American and Black in glossaries and on medical school applications. (Directive to Take Action)
84
BRes. 219American College of Obstetricians and GynecologistsBundling for Maternity Care ServicesRESOLVED, that our American Medical Association advocates for the separate payment of services not accounted for in the valuation of the maternity global codes and opposes the inappropriate bundling of related services. (Directive to Take Action)
85
BRes. 220CaliforniaRestorative Justice for the Treatment of Substance Use DisordersRESOLVED, that our American Medical Association (1) continues to support the right of incarcerated individuals to receive appropriate care for substance use disorders, (2) supports providing incentives for incarcerated individuals to overcome substance use disorders, such as participation in treatment as a condition for early release, and (3) supports providing access to social services and family therapy during and after incarceration (New HOD Policy)

RESOLVED, that our AMA (1) recognizes that criminalization of substance use disproportionately impacts minoritized and disadvantaged communities due to structural racism and implicit bias, (2) acknowledges inequitable sentencing structures, such as towards crack cocaine versus opioids, have contributed to unjust imprisonments, and (3) supports implicit bias and antiracism training for medical professionals working in correctional facilities. (New HOD Policy)
86
BRes. 221CaliforniaReforming Medicare Part B Drug Reimbursement to Promote Patient Affordability and Physician Practice Sustainability RESOLVED, that our American Medical Association support the creation of a new reimbursement model for Part B drugs that 1) Disentangles reimbursement from the drug price, or any weighted market average of the drug price, by reimbursing physicians for the actual cost of the drug, and 2) Ensures adequate compensation for the cost of acquisition, inventory, storage, and administration of clinically-administered drugs that is based on physician costs, not a percent of the drug price (New HOD Policy)

RESOLVED, that our AMA maintain the principles that any revised Part B reimbursement models should promote practice viability, especially for small physician practices, practices in rural and/or underserved areas, and practices with a significant proportion of Medicare patients, to promote continued treatment access for patients. (New HOD Policy)
87
BRes. 222Resident and Fellow SectionStudying Avenues for Parity in Mental Health & Substance Use CoverageRESOLVED, that our American Medical Association study potential penalties to insurers for not complying with mental health and substance use parity laws. (Directive to Take Action)
88
BRes. 223American Academy of PediatricsIncrease in Children’s Hospital Graduate Medical Education FundingRESOLVED, that our American Medical Association collaborate with other relevant medical organizations to support and advocate for increased funding for the Children’s Hospitals Graduate Medical Education program, recognizing the vital role it plays in shaping the future of pediatric healthcare in the United States. (Directive to Take Action)
89
BRes. 224Medical Student SectionAntidiscrimination Protections for LGBTQ+ Youth in Foster CareRESOLVED, that our American Medical Association collaborate with state medical societies and other appropriate stakeholders to support policies on the federal and state levels that establish nondiscrimination protections within the foster care system on the basis of sexual orientation and gender identity (New HOD Policy)

RESOLVED, that our AMA support efforts by the Department of Health and Human Services and other appropriate stakeholders to establish a reporting mechanism for the collection of anonymized and aggregated sexual orientation and gender identity data in the Foster Care Analysis and Reporting System only when strong privacy protections exist (New HOD Policy)

RESOLVED, that our AMA encourage child welfare agencies to implement practices, policies, and regulations that: (a) provide training to child welfare professionals, social workers, and foster caregivers on how to establish safe, stable, and affirming care placements for LGBTQ+ youth; (b) adopt programs to prevent and reduce violence against LGBTQ+ youth in foster care; (c) improve recruitment of foster families that are affirming of LGBTQ+ youth; and (d) allow gender diverse youth to be placed in residential foster homes that are willing to accept their gender identity.
(New HOD Policy)
90
BRes. 225Medical Student SectionHumanitarian Efforts to Resettle RefugeesRESOLVED, that our American Medical Association support increases and oppose decreases to the annual refugee admissions cap in the United States. (New HOD Policy)
91
BRes. 226MissouriProtecting Access to IVF TreatmentRESOLVED, that our American Medical Association oppose any legislation that could criminalize in-vitro fertilization (New HOD Policy)

RESOLVED, that our AMA work with other interested organizations to oppose Court rulings that equate gametes (oocytes and sperm) or embryos with children. (Directive to Take Action)
92
BRes. 227MissouriMedicare Reimbursement for TelemedicineRESOLVED, that our American Medical Association support removal of the December 31, 2024 “sunset” date currently set for Medicare to cease reimbursement for services provided via telemedicine, such that reimbursement of medical services provided by telemedicine be continued indefinitely into the future, consistent with what would be determined by the Relative Value Update Committee (“RUC”). (New HOD Policy)
93
BRes. 228MissouriWaiver of Due Process ClausesRESOLVED, that our American Medical Association advocate that waiver of due process clauses be eliminated from all employment agreements between employed physicians and their non-physician employers, and be declared unenforceable in physicians’ previously-executed employment agreements between physicians and their non-physician employers that currently exist (Directive to Take Action)

RESOLVED, that our AMA will engage in advocacy for adoption of such legislation at the federal level. (Directive to Take Action)
94
BRes. 229IllinoisOpposition to Legalization of PsilocybinRESOLVED, that our American Medical Association oppose any legislative efforts relatable to legalization of Psilocybin/Psilocin or its related substances use. (New HOD Policy)
95
BRes. 230American Academy of DermatologyProtecting Patients from Inappropriate Dentist and Dental Hygienist Scope of Practice ExpansionRESOLVED, that our American Medical Association advocacy efforts recognize the threat posed to patient safety when dentists and dental hygienists are authorized to practice medicine and administer procedures outside their level of education and training (New HOD Policy)

RESOLVED, that our AMA actively oppose regulatory and legislative efforts authorizing dentists and dental hygienists to practice outside their level of education and training. (Directive to Take Action)
96
BRes. 231American College of Medical Genetics and GenomicsSupporting the Establishment of Rare Disease Advisory CouncilsRESOLVED, that our American Medical Association will support state legislation for the establishment of Rare Disease Advisory Councils in each state (New HOD Policy)
97
BRes. 232Association for Clinical OncologyMedicare Advantage Part B Drug CoverageRESOLVED, that our American Medical Association will advocate with Congress, through the appropriate oversight committees, and with the Centers for Medicare & Medicaid Services (CMS) to require that Medicare Advantage (MA) plans cover physician-administered drugs and biologicals in such a way that the patient out of pocket cost is the same or less than the amount that a patient with traditional Medicare plus a Medigap plan would pay (Directive to Take Action)
98
BRes. 233Association for Clinical OncologyProhibiting Mandatory White Bagging RESOLVED, that our American Medical Association urge state and federal policymakers to enact legislation to prohibit the mandatory use of white bagging (Directive to Take Action)
99
BRes. 234Association for Clinical OncologyState Prescription Drug Affordability Boards - Study RESOLVED, that our American Medical Association conduct a study to determine how upper payment limits (UPLs) established by state prescription drug affordability boards (PDABs) will impact reimbursement for physician-administered drugs and what impact state UPLs will have on patient access to care (Directive to Take Action)

RESOLVED, that our AMA report the results of the study on UPLs to the House of Delegates at A-25. (Directive to Take Action)
100
BRes. 235New JerseyEstablish a Cyber-Security Relief FundRESOLVED, that our American Medical Association, through appropriate channels, advocate for a ‘Cyber Security Relief Fund” to be established by Congress (Directive to Take Action)

RESOLVED, that the “Cyber Security Relief Fund” be funded through contributions from health insurance companies and all payers - as a mandated requirement by each of the payer (Directive to Take Action)

RESOLVED, that the “Cyber Security Relief Fund” only be utilized for ‘uninterrupted’ payments to all providers- in a structured way, in the event of future cyber-attacks affecting payments. (Directive to Take Action)
101
BRes. 236DelawareSupport of Physicians Pursuing Collective Bargaining and UnionizationRESOLVED, that our American Medical Association investigate avenues for the AMA and other physician associations to aid physicians in initiating and navigating collective bargaining efforts, encompassing but not limited to unionization. (Directive to Take Action)
102
BRes. 237American College of Preventive MedicineEncouraging the Passage of the Preventive Health Savings Act (S.114)RESOLVED, that our American Medical Association encourages continued advocacy to federal and state legislatures of the importance of more accurately and effectively measuring the health and economic impacts of investing in preventive health services to improve health and reduce healthcare spending costs in the long term. (Directive to Take Action)

RESOLVED, that our AMA reaffirm the following policy: D-155.994, “Value-Based Decision Making in the Health Care System” to encourage legislation and efforts to allow the Congressional Budget Office to more effectively project long-term budget deficit reductions and costs associated with legislation related to preventive health services. (Reaffirm HOD Policy)
103
BRes. 238New YorkAMA Supports Efforts to Fund Overdose Prevention SitesRESOLVED, that our American Medical Association support legislation or regulation that would fund overdose prevention sites. (New HOD Policy)
104
BRes. 239New YorkRequiring stores that sell tobacco products to display NYS Quitline informationRESVOLVED, that our American Medical Association seek federal legislation and/or regulation requiring all stores licensed to sell tobacco or nicotine products to display easily visible information about the CDC hotline 1-800-QUIT-NOW in multiple languages and/or the information for the corresponding state or territory. (Directive to Take Action)
105
BRes. 240New YorkExpanding Visa Requirement Waivers for NY IMGs Working in Underserved AreasRESOLVED, that our American Medical Association supports reauthorization and expansion of the Conrad-30 J-1 visa waiver program, including permitting reallocation of unused slots to states that have already used the maximum number of waivers. (New HOD Policy)
106
BRes. 241New YorkHealthcare Cybersecurity BreachesRESOLVED, that our American Medical Association advocate for the development of an adequately funded multidisciplinary task-force including representation of AMA, health insurers, the FBI and other pertinent stakeholders to prevent future healthcare cyberattacks throughout the country and to increase the apprehension of cybercriminals who prey on patients and healthcare entities, and to recommend appropriate penalties for their crimes. (Directive to Take Action)
107
BRes. 242Minority Affairs SectionCancer Care in Indian Health Services FacilitiesRESOLVED, that our American Medical Association actively advocate for the federal government to continue enhancing and developing alternative pathways for American Indian and Alaska Native patients to access the full spectrum of cancer care and cancer-directed therapies outside of the established Indian Health Service system (Directive to Take Action)

RESOLVED, that our AMA (a) support collaborative research efforts to better understand the limitations of IHS cancer care, including barriers to access, disparities in treatment outcomes, and areas for improvement and (b) encourage cancer linkage studies between the IHS and the CDC to better evaluate regional cancer rates, outcomes, and potential treatment deficiencies among American Indian and Alaska Native populations. (Directive to Take Action)
108
BRes. 243Minority Affairs SectionDisaggregation of Demographic Data for Individuals of Federally Recognized TribesRESOLVED, that our American Medical Association add “Enrolled Member of a Federally Recognized Tribe” on all AMA demographic forms (Directive to Take Action);

RESOLVED, that our AMA advocate for the use of “Enrolled Member of a Federally Recognized Tribe” as an additional category in all uses of demographic data including but not limited to medical records, government data collection and research, and within medical education (Directive to Take Action);

RESOLVED, that our AMA support the Association of American Medical Colleges (AAMC) inclusion of “Enrolled Member of a Federally Recognized Tribe” on all AAMC demographic forms (New HOD Policy);

RESOLVED, that our AMA advocate for the Accreditation Council for Graduate Medical Education (ACGME) to include “Enrolled Member of a Federally Recognized Tribe” on all ACGME demographic forms. (Directive to Take Action)
109
BRes. 244Minority Affairs SectionGraduate Medical Education Opportunities for American Indian and Alaska Native CommunitiesRESOLVED, that our American Medical Association supports policy and communication efforts to (1) advance legislative and regulatory policies and actions that establish, authorize, fund, and incentivize the creation of graduate medical education opportunities in IHS, Tribal-administered, and urban Indian health organizations and facilities and (2) establish associated partnerships with accredited medical schools and teaching hospitals (New HOD Policy)

RESOLVED, that our AMA supports collaboratively working with Tribal nations, Tribal organizations, academic medical centers, policy professionals, medical schools, teaching hospitals, coalition builders, and other stakeholders to advocate to Congress, The White House, the Department of Health and Human Services, and other government entities to establish dedicated graduate medical education funding and programs that benefit Tribal communities, increase physician training sites, and reduce physician shortages, particularly among underserved populations. (New HOD Policy)
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269